Clinakos Spreads Breast Cancer Awareness day
Over 300 million people worldwide are affected by rare diseases. Rare diseases impact the lives of people of all races, religions, and socio-economic status. Clinakos is proud to support the Rare Disease Patients and Life science partners in developing and commercializing cures via our unique data & solution offerings for >700 Rare, Oncology and Non-Rare […]
A New Paradigm of Patient Level Data
Deep, Real-Time, and actual Patient Level Data are changing how Pharma and Biotech companies are developing and commercializing products. In this new world, Patient and Physician journeys are dynamic. Patient drop-offs and abandonments are handled via smart AI models powered by actual patient data. We at Clinakos Inc. are proud to be at the center […]
Clinakos is proud to enable Patient Level Data for our large and small pharma clients
Patient Level Data especially in oncology and rare diseases provides a unique opportunity for pharmaceutical franchise leaders and launch teams. Access to hard-to-find patient populations tying qualitative and quantitative research to real-time linked patient-level medical records including EMR, Lab, Pharmacy, and SODH is key to taking important decisions pre, peri, and post-launch. With patient adoption […]
Clinakos Inc. partners with Rare Patient Voice to provide unique offering
Clinakos Inc. is extremely proud to share our capabilities with Wes Michael and his team at Rare Patient Voice to provide this one of kind offering for our pharmaceutical and biotech clients.
Clinakos is attending ISPOR 2022
Connect with us to set up a meeting to discuss how Patient Level data is disrupting the world of health outcomes.
The Power of Patient Data: New Opportunities for Lifesciences
Over 2,100 registrants signed up to learn how patient data is disrupting life sciences product development and commercialization. The recording of THE POWER OF PATIENT DATA: New Opportunities for Life Sciences from Rare Patient Voice and Clinakos is is now available on LinkedIn at https://lnkd.in/dc_D7fZ6. This event is a must for pharma, biotech, medical affairs, MRX, […]
Clinakos CEO to present at CDISC 2021 US Interchange on October 20, 2021
Clinakos CEO Inder Jaggi has been invited to present at CDISC’s 2021 US Interchange conference. The title of his talk is “Impact of HHS Final Data Blocking Rule on RWD/RWE Generation.” This talk describes the increasingly important role of RWD and RWE in biopharmaceutical research, drug approvals and label extensions. The FDA now has published […]
Webinar Replay: Combining Patient Data with the Patient Voice: A Novel Approach
https://player.vimeo.com/video/605776707?dnt=1&app_id=122963&h=c95704dd1dClinakos and Rare Patient Voice’s webinar was one of Pharmavoice’s most attended webinars of the year. This webinar covered recent technological and regulatory changes that have enabled a novel approach to combing real world data with market research. Combining the patient’s actual medical data with their experience and opinions provides unique insights for pharma and […]
Webinar – Combining Patient Data with the Patient Voice: A Novel Approach
Companies spend billions of dollars on both procuring healthcare data and conducting market research with limited results. This problem is especially acute in oncology and rare diseases where patients are hard to find and their data is often lacking in syndicated or aggregated data sets. Recent technological and regulatory changes have enabled a novel approach […]
ResearchLive covers Clinakos and Rare Patient Voice partnership on patient data
Patient recruitment company Rare Patient Voice has entered a partnership with data business Clinakos to combine patient survey insights with medical profile and behavioural data.
